Company Profile
The company's original non-exogenous contrast agent cerebral perfusion imaging - arterial spin labeling (ASL), benchmarking US GE technology, compared to PET, CTP, PWI technology on the market, non-invasive, no-nuclear, contrast agent injection To avoid the resulting anaphylactic shock, death, kidney damage and brain tissue deposition damage.
The image interpretation calculation can be fully automated and an analysis report can be issued to improve the doctor's diagnosis rate.
The company's original non-exogenous contrast agent cerebral perfusion imaging - arterial spin labeling (ASL), benchmarking US GE technology, compared to PET, CTP, PWI technology on the market, non-invasive, no-nuclear, contrast agent injection To avoid the resulting anaphylactic shock, death, kidney damage and brain tissue deposition damage.
The image interpretation calculation can be fully automated and an analysis report can be issued to improve the doctor's diagnosis rate.